Do A - Search Results

1

Clinical Phenotyping and the Application of Precision Medicine in MAFLD.

Saffo S, Do A. Saffo S, et al. Among authors: do a. Clin Liver Dis (Hoboken). 2022 May 23;19(6):227-233. doi: 10.1002/cld.1199. eCollection 2022 Jun. Clin Liver Dis (Hoboken). 2022. PMID: 35795621 Free PMC article. Review.

2

Epidemiology of nonalcoholic fatty liver disease: A primer.

Do A, Lim JK. Do A, et al. Clin Liver Dis (Hoboken). 2016 May 27;7(5):106-108. doi: 10.1002/cld.547. eCollection 2016 May. Clin Liver Dis (Hoboken). 2016. PMID: 31041041 Free PMC article. Review. No abstract available.

3

Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice.

Ilagan-Ying YC, Banini BA, Do A, Lam R, Lim JK. Ilagan-Ying YC, et al. Among authors: do a. Curr Gastroenterol Rep. 2023 Oct;25(10):213-224. doi: 10.1007/s11894-023-00883-8. Epub 2023 Sep 28. Curr Gastroenterol Rep. 2023. PMID: 37768417 Review.

4

Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials.

Njei B, Do A, McCarty TR, Fortune BE. Njei B, et al. Among authors: do a. J Clin Gastroenterol. 2016 Nov/Dec;50(10):871-881. doi: 10.1097/MCG.0000000000000585. J Clin Gastroenterol. 2016. PMID: 27404293 Free PMC article. Review.

5

Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system.

Ilagan-Ying YC, Xu J, Lim JK, Do A. Ilagan-Ying YC, et al. Among authors: do a. Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):424-429. doi: 10.1097/MEG.0000000000001758. Eur J Gastroenterol Hepatol. 2021. PMID: 32433419 Free PMC article.

6

The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review.

Chen G, Banini B, Do A, Lim JK. Chen G, et al. Among authors: do a. Clin Mol Hepatol. 2023 Feb;29(Suppl):S319-S332. doi: 10.3350/cmh.2022.0366. Epub 2022 Dec 14. Clin Mol Hepatol. 2023. PMID: 36517000 Free PMC article.

7

Broadening Horizons: Why Gastroenterologists Should Consider a Career in Obesity Medicine.

Do A, Xu J. Do A, et al. Dig Dis Sci. 2023 Mar;68(3):725-728. doi: 10.1007/s10620-023-07827-2. Epub 2023 Jan 21. Dig Dis Sci. 2023. PMID: 36670325 No abstract available.

8

Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease.

Yeoh A, Yang Z, Cheung R, Do A, Ahmed A, Wong RJ. Yeoh A, et al. Among authors: do a. J Clin Gastroenterol. 2024 Aug 1;58(7):718-725. doi: 10.1097/MCG.0000000000001921. J Clin Gastroenterol. 2024. PMID: 37678412

9

Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Chen G, Banini BA, Do A, Gunderson C, Zaman S, Lim JK. Chen G, et al. Among authors: do a. Genes (Basel). 2023 Sep 17;14(9):1811. doi: 10.3390/genes14091811. Genes (Basel). 2023. PMID: 37761951 Free PMC article. Review.

10

Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints.

Do A, Ilagan-Ying YC, Mehal WZ, Lim JK. Do A, et al. Expert Opin Drug Discov. 2021 Feb;16(2):125-134. doi: 10.1080/17460441.2020.1811674. Epub 2020 Oct 22. Expert Opin Drug Discov. 2021. PMID: 33086894 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters